Literature DB >> 32162483

Prognostic prediction of apparent diffusion coefficient obtained by diffusion-weighted MRI in mass-forming intrahepatic cholangiocarcinoma.

Shinichiro Yamada1, Yuji Morine1, Satoru Imura1, Tetsuya Ikemoto1, Yusuke Arakawa1, Yu Saito1, Masato Yoshikawa1, Katsuki Miyazaki1, Mitsuo Shimada1.   

Abstract

BACKGROUND: We evaluated apparent diffusion coefficient (ADC) of diffusion-weighted image MRI as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma (IHCC).
METHODS: We enrolled 26 patients who had undergone hepatic resections for mass-forming-type IHCC in this study, and calculated their mean ADC, using diffusion-weighted image MRI (b: 0, 20, 800 seconds/mm2 ; 1.5 T MRI). Patients were divided into the ADCHigh and the ADCLow groups at the median ADC value (n = 13 for both). We also immunohistochemically evaluated hypoxia-inducible factor (HIF)-1α in tumor tissue.
RESULTS: Median age in the ADCLow was older (P = .03), and showed significant higher rate of scirrhous tumor (P = .02). The 5-year overall survival rate in the ADCLow group was significantly worse than in the ADCHigh group (P = .04). In multivariate analysis, hilar tumor, portal vein invasion and low ADC were independent prognostic factors (P < .05). The ADCLow group also had a higher rate of high HIF-1α expression than the ADCHigh group (P < .05). Representative case of ADCLow group showed rich stroma and high HIF-1α expression.
CONCLUSIONS: The ADC values in MRIs can predict IHCC prognosis, and correlated with stromal density and HIF-1α expression.
© 2020 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Entities:  

Keywords:  apparent diffusion coefficient; hypoxia-inducible factor-1; intrahepatic cholangiocarcinoma; magnetic resonance imaging; prognostic prediction

Mesh:

Substances:

Year:  2020        PMID: 32162483     DOI: 10.1002/jhbp.732

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  5 in total

1.  Preoperative prognostic nutritional index predicts short- and long-term outcomes after liver resection in patients with hepatocellular carcinoma.

Authors:  Yu Saito; Satoru Imura; Yuji Morine; Tetsuya Ikemoto; Shinichiro Yamada; Mitsuo Shimada
Journal:  Oncol Lett       Date:  2020-12-31       Impact factor: 2.967

2.  Diffusion-weighted imaging as an imaging biomarker for assessing survival of patients with intrahepatic mass-forming cholangiocarcinoma.

Authors:  Julaluck Promsorn; Kulyada Eurboonyanun; Payia Chadbunchachai; Chaiwat Apivatanasiri; Kosin Wirasorn; Jarin Chindaprasirt; Aumkhae Sookprasert; Mukesh Harisinghani
Journal:  Abdom Radiol (NY)       Date:  2022-06-15

3.  Apparent diffusion coefficient as a valuable quantitative parameter for predicting clinical outcomes in patients with newly diagnosed primary CNS lymphoma.

Authors:  Dong Won Baek; Hee Jeong Cho; Jae Heung Bae; Sang Kyun Sohn; Joon Ho Moon
Journal:  Blood Res       Date:  2020-06-30

4.  Does perfusion computed tomography correlate to pathology in colorectal liver metastases?

Authors:  M J van Amerongen; A M Vos; W van der Woude; I D Nagtegaal; J H W de Wilt; J J Fütterer; J J Hermans
Journal:  PLoS One       Date:  2021-01-26       Impact factor: 3.240

5.  Diagnostic performance of apparent diffusion coefficient values for the differentiation of intrahepatic cholangiocarcinoma from gastrointestinal adenocarcinoma liver metastases.

Authors:  Temel Fatih Yilmaz; Mehmet Ali Gultekin; Hacı Mehmet Turk; Mehmet Besiroglu; Dilek Hacer Cesme; Melih Simsek; Alpay Alkan; Huseyin Toprak
Journal:  Radiol Oncol       Date:  2021-12-22       Impact factor: 2.991

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.